Главная › Немелкоклеточный рак легкого › Миссисипи

Клинические исследования Немелкоклеточный рак легкого в штате Миссисипи

20 исследований по теме Немелкоклеточный рак легкого ищут участников в центрах в штате Миссисипи.

Города в штате Миссисипи

Официальный текст исследования (на английском)

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Hattiesburg Clinic /ID# 248033, Hattiesburg

Набор участниковФаза 3

Возраст от 18 лет · Любой пол · Обновлено 5 окт. 2026 г. · NCT04928846

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
Baptist Cancer Center-Grenada, Grenada
University of Mississippi Medical Center, Jackson
и еще 3

Набор участниковФаза 3

Возраст от 18 лет · Любой пол · Обновлено 5 окт. 2026 г. · NCT04267848

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven

Набор участниковФаза 2

Возраст от 18 лет · Любой пол · Обновлено 2 окт. 2026 г. · NCT07293247

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Local Institution - 0180, Hattiesburg

Набор участниковФаза 2

Возраст от 18 лет · Любой пол · Обновлено 2 окт. 2026 г. · NCT07680764

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
Baptist Cancer Center-Grenada, Grenada
University of Mississippi Medical Center, Jackson
и еще 3

Набор участниковФаза 3

Возраст от 18 лет · Любой пол · Обновлено 1 окт. 2026 г. · NCT06498635

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Baptist Cancer Center, Southaven

Набор участниковФаза 3

Возраст от 18 лет · Любой пол · Обновлено 28 сент. 2026 г. · NCT07144280

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Hattiesburg Clinic Hematology/Oncology ( Site 0104), Hattiesburg

Набор участниковФаза 3

Возраст от 18 лет · Любой пол · Обновлено 25 сент. 2026 г. · NCT06170788

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Hattiesburg Clinic Hematology/Oncology, Hattiesburg

Набор участниковФаза 3

Возраст от 18 лет · Любой пол · Обновлено 25 сент. 2026 г. · NCT07222566

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Jackson Oncology Associates, PLLC, Jackson
Jackson Oncology Associates, PLLC, Jackson

Набор участниковФаза 3

Возраст от 18 лет · Любой пол · Обновлено 25 сент. 2026 г. · NCT06758401

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Research Site, Hattiesburg

Набор участниковФаза 3

Возраст от 18 лет · Любой пол · Обновлено 23 сент. 2026 г. · NCT06357533

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Hattiesburg Clinic Hematology/Oncology, Hattiesburg

Набор участниковФаза 3

Возраст от 18 лет · Любой пол · Обновлено 23 сент. 2026 г. · NCT06561386

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Clinical Study Site, Hattiesburg

Набор участниковФаза 3

Возраст от 18 лет · Любой пол · Обновлено 18 сент. 2026 г. · NCT06767514

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Jackson Oncology Associates - The Hederman Cancer Center, Jackson

Набор участниковФаза 2/3

Возраст от 18 лет · Любой пол · Обновлено 16 сент. 2026 г. · NCT04613596

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

North Mississippi Hematology and Oncology Associates, Tupelo

Набор участниковФаза 3

Возраст от 18 лет · Любой пол · Обновлено 8 сент. 2026 г. · NCT06119581

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
Baptist Cancer Center-Grenada, Grenada
University of Mississippi Medical Center, Jackson
и еще 3

Набор участниковФаза 2

Возраст от 18 лет · Любой пол · Обновлено 3 июн. 2026 г. · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
Baptist Cancer Center-Grenada, Grenada
Baptist Memorial Hospital and Cancer Center-Union County, New Albany
и еще 2

Набор участниковФаза 2

Возраст от 18 лет · Любой пол · Обновлено 6 мая 2026 г. · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
Baptist Cancer Center-Grenada, Grenada
Gulfport Memorial Hospital, Gulfport
и еще 3

Набор участниковФаза 2/3

Возраст от 18 лет · Любой пол · Обновлено 5 мая 2026 г. · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
Baptist Cancer Center-Grenada, Grenada
Baptist Memorial Hospital and Cancer Center-Union County, New Albany
и еще 2

Набор участниковФаза 2

18 Minutes · Любой пол · Обновлено 5 мая 2026 г. · NCT06031688

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
Baptist Cancer Center-Grenada, Grenada
Baptist Memorial Hospital and Cancer Center-Union County, New Albany
и еще 2

Набор участниковНаблюдательное исследование

Возраст от 18 лет · Любой пол · Обновлено 17 мар. 2026 г. · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Hattiesburg

Набор участниковНаблюдательное исследование

Любой возраст · Любой пол · Обновлено 28 окт. 2025 г. · NCT03452774

Источник: ClinicalTrials.gov, данные получены 6 окт. 2026 г.. Каждая исследование устанавливает свои критерии участия; решение о включении принимает исследовательская группа.